IQVIA™ Pharma Deals: PharmaDeals Review: Table of Contents

<< Previous Issue

Mar 2021 (Vol: 2021, Issue: 3)

Next Issue >>

Download pdf of entire issue

Section: Licensing
Boston Pharmaceuticals In-Licenses Another Two Programmes from GSK Published: 23 Mar-2021
By: Michelle Liu
Abstract Fulltext:
Section: Mergers & Acquisitions
Merck & Co. Hands Over US$1.85 B to Acquire Pandion Therapeutics Published: 5 Mar-2021
By: Michelle Liu
Abstract Fulltext:
Takeda Continues Divestment Spree with US$1.3 B Teijin Pharma Deal to Reduce Debt Published: 9 Mar-2021
By: Michelle Liu
Abstract Fulltext:
Amgen Spends US$1.9 B on Five Prime to Boost Cancer Pipeline Published: 11 Mar-2021
By: Michelle Liu
Abstract Fulltext:
Jazz Pharmaceuticals Bets on Cannabis-based Medicines with US$7.2 B GW Pharmaceuticals Buy Published: 31 Mar-2021
By: Neha Madhwani & Michelle Liu
Abstract Fulltext:
Section: Opinion & Analysis
IQVIA Pharma Deals Review of 2020 Published: 17 Mar-2021
By: Heather Cartwright, Michelle Liu & Taskin Ahmed
Abstract Fulltext:
Section: Research & Development
Lilly Partners with Rigel on RIPK1 Inhibitors Published: 2 Mar-2021
By: Michelle Liu
Abstract Fulltext:

Login Problems

Please enter your username or email address and we will email you your login details.